Michael W Handlogten (Michael Handlogten)

Years Active: 2020-2023
Publications (10 Years): 5

University of Notre Dame (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Notre Dame

United States

PHD :: Chemical and Biomolecular Engineering

Publications

Michael W Handlogten, Stefanie Bosley, Sarah Dunn, Jie Zhu, Allison Lee-O'Brien, Lina Li, Jamy Therres, Lina Chakrabarti, Bijay Khanal, Rachel Mowery, Subhashini Arumugam, Judith Klover, Mohammed Taleb, Jason Reier, Diane Hatton, Albert Schmelzer
Accelerated cell culture process development and characterization for cilgavimab/tixagevimab (AZD7442) for the prevention and treatment of COVID-19. Biotechnology and bioengineering (2023)
Kevin S McFarland, Jie Zhu, Pritam Sinharoy, Michael J Betenbaugh, Michael W Handlogten
Engineering redox sensors into CHO cells enables near-real-time quantification of intracellular redox in bioprocesses. Biotechnology and bioengineering 119 (6) (2022)
Michael W Handlogten, Li Peng, Elizabeth A Christian, Weichen Xu, Shihua Lin, Raghavan Venkat, William Dall'Acqua, Sanjeev Ahuja
Prevention of Fab-arm exchange and antibody reduction via stabilization of the IgG4 hinge region. mAbs 12 (1) (2021)
Nicole Swope, Wai Keen Chung, Mingyan Cao, Dana Motabar, Dengfeng Liu, Sanjeev Ahuja, Michael W Handlogten
Impact of enzymatic reduction on bivalent bispecific antibody fragmentation and loss of product purity upon reoxidation. Biotechnology and bioengineering 117 (4) (2020)
Michael W Handlogten, Xiangyang Wang, Sanjeev Ahuja
Online control of cell culture redox potential prevents antibody interchain disulfide bond reduction. Biotechnology and bioengineering 117 (5) (2020)

Michael W Handlogten.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Handlogten)